138 related articles for article (PubMed ID: 37625505)
1. Simvastatin inhibits proliferation and promotes apoptosis of oral squamous cell carcinoma through KLF2 signal.
Kou Y; Zhang Y; Rong X; Yang P; Wang C; Zhou Q; Liu H; Liu B; Li M
J Oral Biosci; 2023 Dec; 65(4):347-355. PubMed ID: 37625505
[TBL] [Abstract][Full Text] [Related]
2. NCAPD2 promotes the malignant progression of oral squamous cell carcinoma via the Wnt/β-catenin pathway.
Ma P; Yu H; Zhu M; Liu L; Cheng L; Han Z; Jin W
Cell Cycle; 2024 Mar; 23(5):588-601. PubMed ID: 38743408
[TBL] [Abstract][Full Text] [Related]
3. CLSPN actives Wnt/β-catenin signaling to facilitate glycolysis and cell proliferation in oral squamous cell carcinoma.
Hou Z; Wu C; Tang J; Liu S; Li L
Exp Cell Res; 2024 Feb; 435(2):113935. PubMed ID: 38237848
[TBL] [Abstract][Full Text] [Related]
4. RELA promotes the progression of oral squamous cell carcinoma via TFAP2A-Wnt/β-catenin signaling.
Yang K; Zhao J; Liu S; Man S
Mol Carcinog; 2023 May; 62(5):641-651. PubMed ID: 36789977
[TBL] [Abstract][Full Text] [Related]
5. LncRNA AC007271.3 promotes cell proliferation, invasion, migration and inhibits cell apoptosis of OSCC via the Wnt/β-catenin signaling pathway.
Shao TR; Zheng ZN; Chen YC; Wu QQ; Huang GZ; Li F; Zeng WS; Lv XZ
Life Sci; 2019 Dec; 239():117087. PubMed ID: 31759044
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of lncRNA IGF2BP2-AS1 inhibits proliferation and migration of oral squamous cell carcinoma cells via the Wnt/β-catenin pathway.
Tong S; Wang X; Guo X; Lu Z
J Oral Pathol Med; 2022 Mar; 51(3):272-280. PubMed ID: 34637162
[TBL] [Abstract][Full Text] [Related]
7. Immunity-related long noncoding RNA WDFY3-AS2 inhibited cell proliferation and metastasis through Wnt/β-catenin signaling in oral squamous cell carcinoma.
Lin X; Ding JM; Zheng XZ; Chen JG
Arch Oral Biol; 2023 Mar; 147():105625. PubMed ID: 36657277
[TBL] [Abstract][Full Text] [Related]
8. Baicalin exerts anti-tumor effects in oral squamous cell carcinoma by inhibiting the microRNA-106b-5p-Wnt/β-catenin pathway via upregulating disabled homolog 2.
Wang X; Zhang Y; Zhang S; Duan L
Arch Oral Biol; 2021 Oct; 130():105219. PubMed ID: 34364169
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA CCAT1 is a prognostic biomarker for the progression of oral squamous cell carcinoma via miR-181a-mediated Wnt/β-catenin signaling pathway.
Li GH; Ma ZH; Wang X
Cell Cycle; 2019 Nov; 18(21):2902-2913. PubMed ID: 31599709
[TBL] [Abstract][Full Text] [Related]
10. Palbociclib induces DNA damage and inhibits DNA repair to induce cellular senescence and apoptosis in oral squamous cell carcinoma.
Wang TH; Chen CC; Leu YL; Lee YS; Lian JH; Hsieh HL; Chen CY
J Formos Med Assoc; 2021 Sep; 120(9):1695-1705. PubMed ID: 33342707
[TBL] [Abstract][Full Text] [Related]
11. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression.
Fang Z; Zhao J; Xie W; Sun Q; Wang H; Qiao B
Cancer Med; 2017 Dec; 6(12):2897-2908. PubMed ID: 29125238
[TBL] [Abstract][Full Text] [Related]
12. The role and mechanism of circ-BNC2 on the malignant progression of oral squamous cell carcinoma.
Xia Y; Hei N; Peng S; Cui Z
Head Neck; 2023 Sep; 45(9):2424-2437. PubMed ID: 37377048
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-485-5p targets keratin 17 to regulate oral cancer stemness and chemoresistance via the integrin/FAK/Src/ERK/β-catenin pathway.
Jang TH; Huang WC; Tung SL; Lin SC; Chen PM; Cho CY; Yang YY; Yen TC; Lo GH; Chuang SE; Wang LH
J Biomed Sci; 2022 Jun; 29(1):42. PubMed ID: 35706019
[TBL] [Abstract][Full Text] [Related]
14. circ_0005379 inhibits the progression of oral squamous cell carcinoma by regulating the miR-17-5p/acyl-CoA oxidase 1 axis.
Zhou HX; Wang LY; Chen S; Wang DD; Fang Z
Hua Xi Kou Qiang Yi Xue Za Zhi; 2021 Aug; 39(4):425-433. PubMed ID: 34409798
[TBL] [Abstract][Full Text] [Related]
15. NCAPG, mediated by miR-378a-3p, regulates cell proliferation, cell cycle progression, and apoptosis of oral squamous cell carcinoma through the GSK-3β/β-catenin signaling.
Li J; Sun S; Li J; Zhao X; Li Z; Sha T; Cui Z
Neoplasma; 2021 Nov; 68(6):1201-1211. PubMed ID: 34585587
[TBL] [Abstract][Full Text] [Related]
16. LncRNA, TUG1 regulates the oral squamous cell carcinoma progression possibly via interacting with Wnt/β-catenin signaling.
Liang S; Zhang S; Wang P; Yang C; Shang C; Yang J; Wang J
Gene; 2017 Apr; 608():49-57. PubMed ID: 28119088
[TBL] [Abstract][Full Text] [Related]
17. Chronic restraint stress promotes the tumorigenic potential of oral squamous cell carcinoma cells by reprogramming fatty acid metabolism via CXCL3 mediated Wnt/β-catenin pathway.
Lou F; Long H; Luo S; Liu Y; Pu J; Wang H; Ji P; Jin X
Exp Neurol; 2023 Jan; 359():114268. PubMed ID: 36343679
[TBL] [Abstract][Full Text] [Related]
18. Silencing KLF16 inhibits oral squamous cell carcinoma cell proliferation by arresting the cell cycle and inducing apoptosis.
Yang L; Shi YL; Ma Y; Ren WW; Pang GM; Liu J
APMIS; 2022 Jan; 130(1):43-52. PubMed ID: 34779529
[TBL] [Abstract][Full Text] [Related]
19. Simvastatin inhibits oral squamous cell carcinoma by targeting TMEM16A Ca
Wang H; Wang T; Zhang Z; Fan Y; Zhang L; Gao K; Luo S; Xiao Q; Sun C
J Cancer Res Clin Oncol; 2021 Jun; 147(6):1699-1711. PubMed ID: 33755783
[TBL] [Abstract][Full Text] [Related]
20. MiR-32-5p promoted epithelial-to-mesenchymal transition of oral squamous cell carcinoma cells via regulating the KLF2/CXCR4 pathway.
Qin SY; Li B; Chen M; Qin MQ; Liu JM; Lv QL
Kaohsiung J Med Sci; 2022 Feb; 38(2):120-128. PubMed ID: 34741382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]